loading
전일 마감가:
$75.13
열려 있는:
$74.82
하루 거래량:
6.33M
Relative Volume:
1.40
시가총액:
$40.53B
수익:
$5.54B
순이익/손실:
$4.18B
주가수익비율:
10.86
EPS:
7
순현금흐름:
$259.90M
1주 성능:
+6.31%
1개월 성능:
+6.74%
6개월 성능:
+9.60%
1년 성능:
-13.60%
1일 변동 폭
Value
$74.10
$76.10
1주일 범위
Value
$68.63
$76.29
52주 변동 폭
Value
$58.93
$95.25

에드워즈라이프사이언시스 Stock (EW) Company Profile

Name
명칭
Edwards Lifesciences Corp
Name
전화
(949) 250-2500
Name
주소
ONE EDWARDS WAY, IRVINE, CA
Name
직원
15,800
Name
트위터
@edwardslifesci
Name
다음 수익 날짜
2025-02-11
Name
최신 SEC 제출 서류
Name
EW's Discussions on Twitter

EW을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Medical Devices icon
EW
Edwards Lifesciences Corp
76.04 40.53B 5.54B 4.18B 259.90M 7.00
Medical Devices icon
ABT
Abbott Laboratories
128.85 225.27B 41.95B 13.40B 6.35B 7.65
Medical Devices icon
BSX
Boston Scientific Corp
101.90 138.41B 17.55B 2.03B 2.37B 1.37
Medical Devices icon
SYK
Stryker Corp
365.06 129.62B 22.60B 2.99B 3.49B 7.76
Medical Devices icon
MDT
Medtronic Plc
84.16 107.92B 33.20B 4.26B 5.47B 3.29

에드워즈라이프사이언시스 Stock (EW) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-01-30 업그레이드 Stifel Hold → Buy
2025-01-16 다운그레이드 Wolfe Research Peer Perform → Underperform
2024-12-16 업그레이드 BofA Securities Neutral → Buy
2024-10-11 재개 Morgan Stanley Equal-Weight
2024-09-18 다운그레이드 Jefferies Buy → Hold
2024-07-31 업그레이드 Daiwa Securities Neutral → Outperform
2024-07-29 업그레이드 Wolfe Research Underperform → Peer Perform
2024-07-25 다운그레이드 BofA Securities Buy → Neutral
2024-07-25 다운그레이드 JP Morgan Overweight → Neutral
2024-07-25 다운그레이드 Robert W. Baird Outperform → Neutral
2024-07-25 다운그레이드 TD Cowen Buy → Hold
2024-07-25 다운그레이드 Truist Buy → Hold
2024-05-30 개시 Goldman Buy
2024-05-22 업그레이드 Citigroup Neutral → Buy
2024-05-14 업그레이드 Deutsche Bank Hold → Buy
2024-03-07 업그레이드 BofA Securities Neutral → Buy
2024-02-02 업그레이드 Wells Fargo Equal Weight → Overweight
2024-01-04 다운그레이드 Evercore ISI Outperform → In-line
2023-12-11 다운그레이드 Citigroup Buy → Neutral
2023-11-28 다운그레이드 Wolfe Research Peer Perform → Underperform
2023-09-26 업그레이드 Oppenheimer Perform → Outperform
2023-07-19 개시 Robert W. Baird Outperform
2023-05-30 재개 Morgan Stanley Overweight
2023-03-29 개시 UBS Neutral
2023-03-08 다운그레이드 Wells Fargo Overweight → Equal Weight
2023-02-06 다운그레이드 Raymond James Outperform → Mkt Perform
2023-01-31 다운그레이드 Bernstein Outperform → Underperform
2023-01-30 다운그레이드 Piper Sandler Overweight → Neutral
2022-12-06 다운그레이드 Stifel Buy → Hold
2022-10-28 다운그레이드 Oppenheimer Outperform → Perform
2022-10-26 개시 Mizuho Buy
2022-10-18 개시 Barclays Overweight
2022-10-12 개시 Jefferies Buy
2022-07-29 다운그레이드 Canaccord Genuity Buy → Hold
2022-04-13 개시 Truist Buy
2022-04-06 개시 Wolfe Research Outperform
2022-03-16 업그레이드 Bernstein Mkt Perform → Outperform
2022-03-02 재개 BofA Securities Neutral
2022-02-02 업그레이드 UBS Neutral → Buy
2022-01-27 재확인 Citigroup Buy
2022-01-27 재확인 Evercore ISI Outperform
2022-01-27 재확인 Raymond James Outperform
2022-01-27 재확인 Stifel Buy
2022-01-27 재확인 UBS Neutral
2021-12-17 업그레이드 JP Morgan Neutral → Overweight
2021-12-15 업그레이드 Citigroup Neutral → Buy
2021-12-10 개시 RBC Capital Mkts Outperform
2021-12-06 업그레이드 Wells Fargo Equal Weight → Overweight
2021-07-30 재확인 Canaccord Genuity Buy
2021-07-30 재확인 Deutsche Bank Hold
2021-07-30 재확인 Jefferies Buy
2021-07-30 재확인 Morgan Stanley Overweight
2021-07-30 재확인 Oppenheimer Outperform
2021-07-30 재확인 Stifel Buy
2021-07-30 재확인 UBS Neutral
2021-07-30 재확인 Wells Fargo Equal Weight
2021-05-25 개시 Barclays Overweight
2021-04-15 개시 Atlantic Equities Neutral
2021-04-05 업그레이드 Evercore ISI In-line → Outperform
2020-12-16 다운그레이드 Citigroup Buy → Neutral
2020-12-11 재확인 Canaccord Genuity Buy
2020-09-11 개시 Wolfe Research Underperform
2020-04-28 다운그레이드 Wells Fargo Overweight → Equal Weight
2020-04-17 업그레이드 SVB Leerink Mkt Perform → Outperform
2020-03-05 개시 Citigroup Buy
2020-02-13 개시 Goldman Neutral
2020-02-06 재개 BTIG Research Neutral
2020-01-10 개시 Oppenheimer Outperform
2020-01-02 다운그레이드 Evercore ISI Outperform → In-line
2019-10-24 재확인 Canaccord Genuity Buy
2019-09-23 개시 Piper Jaffray Overweight
2019-07-24 재확인 BofA/Merrill Buy
2019-03-18 재확인 Canaccord Genuity Buy
2019-01-18 업그레이드 BofA/Merrill Neutral → Buy
2019-01-03 개시 Deutsche Bank Hold
2018-11-28 개시 UBS Neutral
2018-10-16 개시 Barclays Underweight
2018-10-02 다운그레이드 BofA/Merrill Buy → Neutral
2018-10-02 다운그레이드 Guggenheim Buy → Neutral
모두보기

에드워즈라이프사이언시스 주식(EW)의 최신 뉴스

pulisher
Apr 26, 2025

Edwards Lifesciences Corporation (NYSE:EW) Q1 2025 Earnings Call Transcript - Insider Monkey

Apr 26, 2025
pulisher
Apr 25, 2025

Edwards Lifesciences Reports Robust Q1 2025 Growth - TipRanks

Apr 25, 2025
pulisher
Apr 25, 2025

Edwards Lifesciences (EW) Price Target Raised by Canaccord Analy - GuruFocus

Apr 25, 2025
pulisher
Apr 24, 2025

Edwards Lifesciences Stock Earns Analyst Upgrade As Growth Outlook Brightens - Benzinga

Apr 24, 2025
pulisher
Apr 24, 2025

Edwards Lifesciences (NYSE:EW) Projects 2025 Sales Over US$5.7 Billion With Strong Earnings - Yahoo Finance

Apr 24, 2025
pulisher
Apr 24, 2025

Edwards Lifesciences Corp (EW) Shares Up 7.25% on Apr 24 - GuruFocus

Apr 24, 2025
pulisher
Apr 24, 2025

This Edwards Lifesciences Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday - Benzinga

Apr 24, 2025
pulisher
Apr 24, 2025

Bernstein Adjusts Price Target on Edwards Lifesciences to $80 From $78 - marketscreener.com

Apr 24, 2025
pulisher
Apr 24, 2025

Edwards Lifesciences (EW) Price Target Raised by Baird Amid Mixed Q1 Results | EW Stock News - GuruFocus

Apr 24, 2025
pulisher
Apr 24, 2025

Edwards Lifesciences (EW) Receives Upgrade from Piper Sandler, Target Raised | EW Stock News - GuruFocus

Apr 24, 2025
pulisher
Apr 24, 2025

Edwards Lifesciences Corp (EW) Q1 2025 Earnings Call Highlights: Strong Sales Growth and ... - Yahoo Finance

Apr 24, 2025
pulisher
Apr 24, 2025

Earnings call transcript: Edwards Lifesciences Q1 2025 beats EPS forecast - Investing.com

Apr 24, 2025
pulisher
Apr 24, 2025

Earnings call transcript: Edwards Lifesciences Q1 2025 beats EPS forecast By Investing.com - Investing.com UK

Apr 24, 2025
pulisher
Apr 24, 2025

Edwards Lifesciences Corp (EW) Q1 2025 Earnings Call Highlights: Strong Sales Growth and Strategic Milestones - GuruFocus

Apr 24, 2025
pulisher
Apr 24, 2025

Edwards Lifesciences Reports Strong Q1 Growth - TipRanks

Apr 24, 2025
pulisher
Apr 23, 2025

Edwards Lifesciences (EW) Reports Strong Q1 2025 Growth on Cardiac Platform Success - GuruFocus

Apr 23, 2025
pulisher
Apr 23, 2025

Edwards Lifesciences Raises 2025 Sales Forecast Amid Currency Boost - Finimize

Apr 23, 2025
pulisher
Apr 23, 2025

Edwards posts Street-beating Q1 results, ups 2025 sales guidance - MassDevice

Apr 23, 2025
pulisher
Apr 23, 2025

Edwards Lifesciences Corp reports results for the quarter ended March 31Earnings Summary - TradingView

Apr 23, 2025
pulisher
Apr 23, 2025

Edwards Lifesciences (EW) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance

Apr 23, 2025
pulisher
Apr 23, 2025

Edwards Lifesciences Corp Q1 2025 Earnings: EPS of $0.62 Beats E - GuruFocus

Apr 23, 2025
pulisher
Apr 23, 2025

Edwards Lifesciences raises 2025 sales forecast after robust quarter - marketscreener.com

Apr 23, 2025
pulisher
Apr 23, 2025

Edwards Lifesciences Q1 Adjusted Earnings, Sales Rise; Provides Q2 Guidance - marketscreener.com

Apr 23, 2025
pulisher
Apr 23, 2025

Edwards Lifesciences Delivers In-Line Sales, Narrow Profit Beat - MSN

Apr 23, 2025
pulisher
Apr 23, 2025

Innovative Strategy Boosts Edwards Lifesciences (EW) Q1 Revenue Above Expectations | EW Stock News - GuruFocus

Apr 23, 2025
pulisher
Apr 23, 2025

Edwards Lifesciences Reports First Quarter Results - TradingView

Apr 23, 2025
pulisher
Apr 23, 2025

Edwards Lifesciences Corp. Reveals Climb In Q1 Profit - Nasdaq

Apr 23, 2025
pulisher
Apr 23, 2025

Earnings Flash (EW) Edwards Lifesciences Reports Q1 Adjusted EPS $0.64, vs. FactSet Est of $0.60 - marketscreener.com

Apr 23, 2025
pulisher
Apr 23, 2025

Edwards Lifesciences Crushes Q1 Expectations: TMTT Sales Surge 58%, New SAPIEN M3 Approval Fuels Growth - Stock Titan

Apr 23, 2025
pulisher
Apr 23, 2025

Edwards Lifesciences Corp (EW) Q1 2025 Earnings Call Highlights: Strong Sales Growth and ... By GuruFocus - Investing.com Canada

Apr 23, 2025
pulisher
Apr 18, 2025

Edwards touts 8-year data for Resilia valve tissue - MassDevice

Apr 18, 2025
pulisher
Apr 18, 2025

Unlocking Q1 Potential of Edwards Lifesciences (EW): Exploring Wall Street Estimates for Key Metrics - Yahoo Finance

Apr 18, 2025
pulisher
Apr 18, 2025

Edwards Lifesciences (EW) Shares Surge on Promising Aortic Valve Study Results | EW Stock News - GuruFocus

Apr 18, 2025
pulisher
Apr 18, 2025

Breakthrough: Edwards Heart Valves Achieve 99.3% Success Rate in Landmark 8-Year Study - Stock Titan

Apr 18, 2025
pulisher
Apr 17, 2025

Is Edwards Lifesciences Gaining or Losing Market Support? - Benzinga

Apr 17, 2025
pulisher
Apr 17, 2025

Solid TMTT Growth to Drive Edwards Lifesciences' Q1 Earnings - MSN

Apr 17, 2025
pulisher
Apr 16, 2025

Edwards Lifesciences to Host Earnings Conference Call on April 23, 2025 - marketscreener.com

Apr 16, 2025
pulisher
Apr 15, 2025

Edwards Lifesciences Insider Sold Shares Worth $663,196, According to a Recent SEC Filing - marketscreener.com

Apr 15, 2025
pulisher
Apr 15, 2025

Edwards Lifesciences CVP Donald Bobo Jr. sells $663k in stock - Investing.com Australia

Apr 15, 2025
pulisher
Apr 15, 2025

Edwards Lifesciences (EW) Secures CE Mark for Innovative Mitral Valve System | EW Stock News - GuruFocus

Apr 15, 2025
pulisher
Apr 14, 2025

Edwards SAPIEN M3 Receives CE Mark, Becoming World’s First Transfemoral Transcatheter Mitral Valve Replacement System - BioSpace

Apr 14, 2025
pulisher
Apr 14, 2025

Edwards Lifesciences CVP Donald Bobo Jr. sells $663k in stock By Investing.com - Investing.com South Africa

Apr 14, 2025
pulisher
Apr 14, 2025

Edwards lands first CE mark for transfemoral mitral valve replacement - BioWorld MedTech

Apr 14, 2025
pulisher
Apr 14, 2025

Edwards Lifesciences Gets CE Mark for Sapien M3 Mitral Valve System - marketscreener.com

Apr 14, 2025
pulisher
Apr 14, 2025

Edwards Sapien M3 Receives CE Mark, Becoming World'S First Transfemoral Transcatheter Mitral Valve Replacement System - MarketScreener

Apr 14, 2025
pulisher
Apr 14, 2025

Edwards wins CE mark for Sapien M3 transfemoral heart valve - MassDevice

Apr 14, 2025
pulisher
Apr 14, 2025

Breakthrough: First-Ever Transcatheter Mitral Valve Replacement Gets CE Mark Approval - Stock Titan

Apr 14, 2025
pulisher
Apr 13, 2025

Investors in Edwards Lifesciences Corporation Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your RightsEW - marketscreener.com

Apr 13, 2025
pulisher
Apr 11, 2025

Edwards Lifesciences Stock: A Deep Dive Into Analyst Perspectives (9 Ratings) - Benzinga

Apr 11, 2025
pulisher
Apr 11, 2025

Truist Cuts Price Target on Edwards Lifesciences to $75 From $78, Keeps Hold Rating - marketscreener.com

Apr 11, 2025
pulisher
Apr 10, 2025

Edwards Lifesciences’ Quarterly Earnings Preview: What You Need to Know - Nasdaq

Apr 10, 2025

에드워즈라이프사이언시스 (EW) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$71.66
price up icon 1.24%
$68.42
price up icon 2.00%
medical_devices PHG
$25.03
price up icon 1.25%
medical_devices STE
$225.00
price down icon 0.60%
medical_devices ZBH
$101.51
price up icon 0.01%
자본화:     |  볼륨(24시간):